A Phase II, Single-Stage, Single Arm Investigation of Oral Valganciclovir Therapy in Infants with Asymptomatic Congenital Cytomegalovirus Infection

Grant

Date/time Interval

  • July 1, 2016 - June 30, 2021
  • Total Award Amount

  • 3716696.00
  • Direct Costs

  • 3145076.00
  • Sponsor Award Id

  • HHSN272201600017C
  • Contributor

  • Aban, Inmaculada   Investigator  
  • Acosta Pharm.D., Edward   Investigator  
  • Boppana M.D., Suresh   Investigator  
  • Fowler, Karen   Investigator  
  • James, Scott   Investigator  
  • Kimberlin M.D., David   Principal Investigator  
  • Whitley M.D., Richard   Investigator